| 3-month survival | 6-month survival | 1-year survival | 2-year survival | % patients with the feature | ||||
---|---|---|---|---|---|---|---|---|---|
Predictor‡ | OR†| 95% CI | OR†| 95% CI | OR†| 95% CI | OR†| 95% CI |  |
Diagnoses at PMV onset (excluding respiratory failure) | |||||||||
Neoplasms | 0.30** | 0.27-0.34 | 0.31** | 0.27-0.36 | 0.30** | 0.26-0.35 | 0.31** | 0.26-0.38 | 13.6 |
Acute and unspecified renal failure | 0.39** | 0.34-0.45 | 0.40** | 0.35-0.47 | 0.48** | 0.41-0.57 | 0.56** | 0.47-0.67 | 7.7 |
Shock | 0.42** | 0.38-0.47 | 0.47** | 0.42-0.53 | 0.55** | 0.48-0.62 | 0.63** | 0.55-0.73 | 11.2 |
Chronic renal failure | 0.44** | 0.37-0.51 | 0.43** | 0.36-0.52 | 0.41** | 0.33-0.50 | 0.43** | 0.34-0.54 | 6.3 |
Septicemia | 0.52** | 0.48-0.57 | 0.56** | 0.51-0.61 | 0.60** | 0.54-0.66 | 0.63** | 0.56-0.70 | 20.3 |
Non-alcoholic liver disease | 0.60** | 0.51-0.71 | 0.67** | 0.56-0.81 | 0.72** | 0.60-0.88 | 0.84 | 0.69-1.03 | 4.5 |
Heart failure | 0.77** | 0.68-0.87 | 0.76** | 0.67-0.86 | 0.79** | 0.69-0.91 | 0.77** | 0.66-0.90 | 9.1 |
Diabetes mellitus | 0.78** | 0.71-0.85 | 0.77** | 0.70-0.85 | 0.72** | 0.65-0.79 | 0.73** | 0.65-0.81 | 21.0 |
Disease history (number of admissions for the disease in the previous year; excluding respiratory failure) | |||||||||
Other diseases of the blood and blood-forming organs | 0.85** | 0.80-0.91 | 0.83** | 0.77-0.90 | 0.78** | 0.72-0.86 | 0.80** | 0.73-0.89 | 12.6 |
Non-alcoholic liver disease | 0.86** | 0.80-0.93 | 0.86** | 0.79-0.94 | 0.89* | 0.81-0.98 | 0.92 | 0.83-1.01 | 6.8 |
Neoplasms | 0.91** | 0.88-0.95 | 0.89** | 0.84-0.93 | 0.88** | 0.83-0.93 | 0.89** | 0.84-0.94 | 14.4 |
Chronic renal failure | 0.91** | 0.85-0.97 | 0.88** | 0.81-0.95 | 0.83** | 0.75-0.92 | 0.78** | 0.69-0.89 | 6.9 |
Gender (ref: female) | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Male | 0.89** | 0.83-0.95 | 0.84** | 0.78-0.90 | 0.79** | 0.74-0.85 | 0.78** | 0.72-0.84 | 60.1 |
Age group (ref: 17-34) | Â | Â | Â | Â | Â | Â | Â | Â | Â |
35-44 | 0.67** | 0.51-0.87 | 0.64** | 0.49-0.83 | 0.61** | 0.47-0.79 | 0.65** | 0.51-0.84 | 3.3 |
45-54 | 0.67** | 0.52-0.85 | 0.60** | 0.48-0.76 | 0.54** | 0.43-0.69 | 0.55** | 0.44-0.70 | 6.2 |
55-64 | 0.62** | 0.49-0.78 | 0.52** | 0.41-0.65 | 0.43** | 0.35-0.54 | 0.39** | 0.32-0.49 | 11.2 |
65-74 | 0.44** | 0.36-0.55 | 0.36** | 0.29-0.44 | 0.28** | 0.23-0.35 | 0.25** | 0.20-0.31 | 26.7 |
75-84 | 0.36** | 0.29-0.44 | 0.27** | 0.21-0.33 | 0.19** | 0.15-0.23 | 0.16** | 0.13-0.20 | 35.2 |
≥ 85 | 0.29** | 0.23-0.36 | 0.21** | 0.17-0.26 | 0.15** | 0.12-0.19 | 0.11** | 0.09-0.14 | 14.7 |
Number of patients | Â | 19,127* | Â | 19,127* | Â | 19,127* | Â | 19,127* | 25,482* |
Model significance (results from log-likelihood ratio tests) | χ2(103) = 3,099.81** | χ2(103) = 3,032.36** | χ2(103) = 2,939.46** | χ2(103) = 2,652.06** |  |